Matthias Birkhoff, Vice President Business Development at Aptar Pharma, and Christophe Marie, Director Product Sustainability at AptarGroup, have penned an article that provides a practical comparison of its Ophthalmic Squeeze Dispenser (OSD) and traditional Blow-Fill-Seal (BFS) single use eye drops and their inherent differences from plastics waste and waste formulation perspectives. Based on LCA calculations with Aptar’s Eco-Design tool, savings of CO2 emissions due to considerable packaging material reduction with the OSD multi-dose versus BFS single-use vials have been evaluated. Furthermore, the Eco-Design tool helps Aptar Pharma to develop or optimize its devices that maximize sustainability and minimize their impact on the environment.
The article includes numerous real-life examples of how Aptar Pharma’s sustainability initiatives have resulted in measurable improvements for its drug delivery technologies through such design and optimization.
Learn more about Aptar Pharma Expertise
This Might Also Be of Interest
![](https://aptar.com/wp-content/uploads/2022/10/Ophthalmic-Squeeze-Dispenser_vs_Blow-Fill-Seal_Updated-1024x833.jpg)
Case Study – Ophthalmic Squeeze Dispenser and ESG
Case Studies, Pharmaceutical, Sustainability, Device Innovations, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2022/10/IPI_Oct2022_2.jpg)
Under Pressure: Finding a More Sustainable Future for pMDIs
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2022/05/Thumbnail_Webinar_RespiratoryRoundtable_2022_May17.jpg)
Roundtable: Evolution of Pressurized Metered Dose Inhalers to Cut Carbon Emissions
Webinars, Pharmaceutical, Sustainability, Device Innovations, Market Insights, Product Solutions
![](https://aptar.com/wp-content/uploads/2022/04/ONDD_April2022.jpg)
Investigating The Propellant Pathways Leading To a Sustainable Future of MDIs
Publications, Pharmaceutical, Sustainability, Device Innovations, Product Solutions